Article ; Online: Successful treatment of Langerhans cell histiocytosis in an infant with vemurafenib: a case report and literature review.
The Journal of dermatological treatment
2023 Volume 34, Issue 1, Page(s) 2279901
Abstract: Langerhans cell histiocytosis (LCH) is a histiocytic neoplasm characterized by a mass of CD1a + CD207 + histiocytes, exhibiting a diverse range of clinical manifestations from a self-healing rash or single bone destruction to multi-organ disease with ... ...
Abstract | Langerhans cell histiocytosis (LCH) is a histiocytic neoplasm characterized by a mass of CD1a + CD207 + histiocytes, exhibiting a diverse range of clinical manifestations from a self-healing rash or single bone destruction to multi-organ disease with potentially fatal consequences. The identification of MAPK signaling pathway activation, particularly BRAF |
---|---|
MeSH term(s) | Humans ; Infant ; Vemurafenib/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics ; Histiocytosis, Langerhans-Cell/drug therapy ; Histiocytosis, Langerhans-Cell/diagnosis ; Histiocytosis, Langerhans-Cell/genetics ; Protein Kinase Inhibitors/therapeutic use ; Treatment Outcome ; Mutation |
Chemical Substances | Vemurafenib (207SMY3FQT) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Protein Kinase Inhibitors |
Language | English |
Publishing date | 2023-11-09 |
Publishing country | England |
Document type | Review ; Case Reports ; Journal Article |
ZDB-ID | 1036299-x |
ISSN | 1471-1753 ; 0954-6634 |
ISSN (online) | 1471-1753 |
ISSN | 0954-6634 |
DOI | 10.1080/09546634.2023.2279901 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2627: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.